These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 7502900

  • 1. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U.
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract] [Full Text] [Related]

  • 2. [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].
    Kapellerová A, Sulko M, Krovinová A, Jakubovská M, Michalicková J, Mazáriková O.
    Cesk Pediatr; 1989 Aug; 44(8):454-8. PubMed ID: 2791096
    [Abstract] [Full Text] [Related]

  • 3. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M, Pitzke P, Grevers G, van Aubel A, Elsasser U, Kämmereit A.
    Adv Ther; 1998 Aug; 15(6):330-41. PubMed ID: 10351117
    [Abstract] [Full Text] [Related]

  • 4. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M, Eckenberger HP.
    Fortschr Med; 1992 Nov 30; 110(30):565-70. PubMed ID: 1468743
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S, Tazza R.
    Arzneimittelforschung; 2004 Nov 30; 54(1):50-6. PubMed ID: 14979609
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D, Varricchio A, D'Ambrosio S, Ascione E, Motta G.
    Arzneimittelforschung; 2004 Nov 30; 54(1):57-63. PubMed ID: 14979610
    [Abstract] [Full Text] [Related]

  • 7. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N, Agriesti G, Testa A, Borgarello R, Capo G, Crua G.
    Minerva Pediatr; 1988 Jun 30; 40(6):355-60. PubMed ID: 3054472
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV, Vinnikov AK.
    Vestn Otorinolaringol; 2001 Jun 30; (1):40. PubMed ID: 11247247
    [No Abstract] [Full Text] [Related]

  • 12. Effect of pneumococcal vaccination on upper respiratory tract infections in children. Design of a follow-up study.
    Rosén C, Christensen P, Hovelius B, Prellner K.
    Scand J Infect Dis Suppl; 1983 Jun 30; 39():39-44. PubMed ID: 6359379
    [Abstract] [Full Text] [Related]

  • 13. Prevention of infections of the respiratory tract using the oral application of antigens.
    Tischner H.
    Z Erkr Atmungsorgane; 1991 Jun 30; 176(2-3):131-7. PubMed ID: 1858413
    [No Abstract] [Full Text] [Related]

  • 14. [Use of a polyvalent oral bacterial vaccine in recurrent respiratory infections in children].
    Scotti L, Biondelli G, Borzani M.
    Minerva Pediatr; 1987 Apr 15; 39(7):251-6. PubMed ID: 3614148
    [No Abstract] [Full Text] [Related]

  • 15. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB, d'Hinterland LD, Pinel AM, Guendon R, Guerrero A, Préault M.
    Nouv Presse Med; 1975 Feb 01; 4(5):333-6. PubMed ID: 1093123
    [No Abstract] [Full Text] [Related]

  • 16. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P, Brachmann I, Werchan D, Wittig C, Tischner H.
    Z Erkr Atmungsorgane; 1990 Feb 01; 175(2):95-9. PubMed ID: 2264367
    [Abstract] [Full Text] [Related]

  • 17. Bacterial lysates in the prevention of respiratory tract infections.
    Jurkiewicz D, Zielnik-Jurkiewicz B.
    Otolaryngol Pol; 2018 Oct 31; 72(5):1-8. PubMed ID: 30460909
    [Abstract] [Full Text] [Related]

  • 18. [Vaccine therapy in inflammatory diseases of the respiratory organs].
    Egorova NB, Efremova VI, Androsov VV, Beĭlina VB, Veshkina AI.
    Sov Med; 1988 Oct 31; (12):43-7. PubMed ID: 3071866
    [No Abstract] [Full Text] [Related]

  • 19. [Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].
    Chen AH, Chen RC, Zhang CQ, Chen D, Huang S, Lin Y, Zhan J, Zhong N.
    Zhonghua Er Ke Za Zhi; 2004 Jun 31; 42(6):463-4. PubMed ID: 15265442
    [No Abstract] [Full Text] [Related]

  • 20. Mucosal vaccination against bacterial respiratory infections.
    Baumann U.
    Expert Rev Vaccines; 2008 Oct 31; 7(8):1257-76. PubMed ID: 18844598
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.